Camlin Fine SciencesNSE:CAMLINFINE +0.36%56 Return-on-Tangible-Equity is 45.31% as of Mar. 2026, which is 2417% above its 10-year median of 1.80. GuruFocus rates NSE:CAMLINFINE with a GF Score™ of 56/100 and a GF Value™ of ₹142.75 (Fairly Valued). The stock has 4 warning signs investors should review. Among 1,571 Chemicals companies, Camlin Fine Sciences ranks worse than 62.32% on this metric.
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Camlin Fine Sciences's annualized net income for the quarter that ended in Mar. 2026 was ₹3,528 Mil. Camlin Fine Sciences's average shareholder tangible equity for the quarter that ended in Mar. 2026 was ₹7,786 Mil. Therefore, Camlin Fine Sciences's annualized Return-on-Tangible-Equity for the quarter that ended in Mar. 2026 was 45.31%.
The historical rank and industry rank for Camlin Fine Sciences's Return-on-Tangible-Equity or its related term are showing as below:
NSE:CAMLINFINE'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: -16.87 Med: 1.8 Max: 11.22
Current: 3.39
During the past 13 years, Camlin Fine Sciences's highest Return-on-Tangible-Equity was 11.22%. The lowest was -16.87%. And the median was 1.80%.
NSE:CAMLINFINE's Return-on-Tangible-Equity is ranked worse than 62.32% of 1571
companies
in the Chemicals industry
Industry Median: 5.7
vs NSE:CAMLINFINE: 3.39
Camlin Fine Sciences (NSE:CAMLINFINE) Return-on-Tangible-Equity Explanation
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Camlin Fine Sciences Return-on-Tangible-Equity Related Terms
Camlin Fine Sciences Return-on-Tangible-Equity Historical Data
* Premium members only.
The historical data trend for Camlin Fine Sciences's Return-on-Tangible-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Camlin Fine Sciences Return-on-Tangible-Equity Chart
NSE:CAMLINFINE vs LIN, SHW, ECL: Return-on-Tangible-Equity Comparison
For the Specialty Chemicals subindustry, Camlin Fine Sciences's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Camlin Fine Sciences Return-on-Tangible-Equity vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Camlin Fine Sciences's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Camlin Fine Sciences's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 45.31% mean?
Camlin Fine Sciences (NSE:CAMLINFINE) has a Return-on-Tangible-Equity of 45.31% as of Mar. 2026. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Camlin Fine Sciences and its competitors. This is 2417% above median its historical median of 1.80. According to the industry distribution chart, Camlin Fine Sciences ranks #979 out of 1571 companies in the Chemicals industry, placing it in the top 62.3%.
Is Camlin Fine Sciences' Return-on-Tangible-Equity too high?
Camlin Fine Sciences' current Return-on-Tangible-Equity of 45.31% is 2417% above median its 10-year median of 1.80. The Chemicals industry median Return-on-Tangible-Equity is 5.70. Camlin Fine Sciences' value of 45.31% is 694.9% above this industry median. Based on the distribution chart, Camlin Fine Sciences ranks #979 out of 1571 companies in the Chemicals industry, which is below the industry midpoint. Overall, Camlin Fine Sciences has a GF Score™ of 56/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Camlin Fine Sciences' Return-on-Tangible-Equity compare to LIN and SHW?
According to the Chemicals industry distribution chart, Camlin Fine Sciences ranks #979 out of 1571 companies for Return-on-Tangible-Equity. This places Camlin Fine Sciences in the lower half of its industry. The industry median Return-on-Tangible-Equity is 5.70. Camlin Fine Sciences' value of 45.31% is 694.9% above this benchmark. While the company's 10-year median is 1.80 vs. the industry median of 5.70, Camlin Fine Sciences has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Chemicals company?
The median Return-on-Tangible-Equity among Chemicals companies is 5.70, based on 1,571 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Camlin Fine Sciences's current Return-on-Tangible-Equity of 45.31% is 694.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Camlin Fine Sciences and its competitors. For the Chemicals industry, the median Return-on-Tangible-Equity is 5.70 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Camlin Fine Sciences's current Return-on-Tangible-Equity is 45.31%, which is 2417% above median its own 10-year median of 1.80. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Camlin Fine Sciences stock overvalued right now?
Based on GuruFocus' analysis, Camlin Fine Sciences (NSE:CAMLINFINE) is currently considered Fairly Valued. The stock's GF Value™ is ₹142.75, compared to a current price of ₹136.76 — trading 4.2% below its estimated fair value. The current Return-on-Tangible-Equity is 45.31%, which is 2417% above median its 10-year median of 1.80 and 694.9% above the Chemicals industry median of 5.70. Camlin Fine Sciences' overall GF Score™ is 56/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Camlin Fine Sciences (NSE:CAMLINFINE), the current Return-on-Tangible-Equity is 45.31% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Camlin Fine Sciences (NSE:CAMLINFINE) Overvalued in 2026?
Based on GuruFocus' analysis, Camlin Fine Sciences stock appears to be undervalued.
The current stock price of ₹136.76 is trading 4.2% below its estimated GF Value™ of ₹142.75.
GuruFocus considers Camlin Fine Sciences to be Fairly Valued.
Key valuation signals for NSE:CAMLINFINE:
Return-on-Tangible-Equity: 45.31% (2417% above median its 10-year median of 1.80)
GF Value™: ₹142.75 vs. price of ₹136.76 (4.2% below fair value)
Industry Position: 694.9% above the Chemicals median (#979 of 1571)
No single metric tells the full story. See the NSE:CAMLINFINE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Camlin Fine Sciences Ltd is engaged in research, development, manufacturing, commercializing, and marketing of specialty chemicals and blends. These chemicals are used in food, feed, animal and pet nutrition and industrial products. The Company has only one reportable segment, namely, Speciality Chemicals. The company's product portfolio consists of Shelf life solutions, Aroma ingredients, Performance chemicals and Health & Wellness. Shelf life extension solutions include antioxidant solutions which are used to increase the shelf life of oils and. Aroma vertical includes a production of Vanillin and Ethyl Vanillin. Performance Chemicals consist of Guaiacol, Veratrole, TBC, and MEHQ and are used in sectors such as food flavoring, pharmaceuticals intermediate fragrance industry.
56GF Score
Get the complete analysis for NSE:CAMLINFINE
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:CAMLINFINE has been successfully added to your 
